Methodological considerations in the assessment of noninvasive testing using outcomes research: Pitfalls and limitations

Progress in Cardiovascular Diseases

Volumn 43, Issue 3, 2000, Pages 215-230

  Hachamovitch, Rory ^a,b   Shaw, Leslee ^a,b,c   Berman, Daniel S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY RISK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE QUALITY; HUMAN; OUTCOMES RESEARCH; PROGNOSIS; RESOURCE ALLOCATION; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034537607     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2000.19313     Document Type: Article

References (39)

1. Diagnosis and treatment of coronary disease: Comparison of doctors' attitudes in the USA and the UK
2. How coronary angiography is used. Clinical determinants of appropriateness
3. The appropriateness of performing coronary angiography in two major teaching hospitals in Israel
4. The appropriateness of use of coronary artery bypass graft surgery in New York State
5. The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State
6. Measuring the clinical appropriateness of the use of a procedure. Can we do it?
7. The appropriateness of use of coronary angiography in New York State
8. Statistical, epidemiological and fiscal issues in the evaluation of patients with coronary artery disease
9. Regression modelling strategies for improved prognostic prediction
10. Regression models for prognostic prediction: Advantages, problems, and suggested solutions
11. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
12. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II
13. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I
14. The declining specificity of exercise radionuclide ventriculography
15. The pathogenesis of coronary artery disease and the acute coronary syndromes
16. Cardiovascular disorders
17. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease
18. Monitoring the quality of life in patients with coronary artery disease
19. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index
20. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo
21. Prognostic assessment in chronic coronary artery disease. American College of Cardiology Highlights
22. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography
23. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification
24. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction
25. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precatheterization ischemia
26. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia
27. Risk assessment in patients with stable coronary artery disease: Incremental value of nuclear imaging
28. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease
29. Prognostic value of thallium-201 myocardial perfusion imaging: A diagnostic tool comes of age
30. Incremental prognostic value of adenosine myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease
31. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography
32. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain
33. Noninvasive strategies for the estimation of cardiac risk: An observational assessment of outcome in stable chest pain patients